The Academy is pursuing a two-pronged strategy through Congress and the Department of Education to protect federal student loan access for AuD students. Both pathways require immediate action from audiologists and students.
Legislative Action: The Professional Student Degree Act
The Professional Student Degree Act (H.R. 6718), introduced by Representative Michael Lawler (R-NY), would reaffirm audiology as a professional degree program under federal law. The bill updates the Higher Education Act to explicitly include audiology, ensuring AuD students remain eligible for higher federal student loan limits for doctoral-level clinical education. H.R. 6718 currently has four cosponsors, and increased congressional support is needed for the bill to advance in 2026.
Contact Congress: Ask your U.S. Representative to cosponsor H.R. 6718.
Regulatory Action: Department of Education Rulemaking
At the same time, the U.S. Department of Education has proposed regulations redefining which programs qualify as “professional degree programs.” Under the draft rule, only 11 named professions would retain higher federal loan limits, and audiology was not included. If finalized, this could significantly limit borrowing for AuD students as early as July 2026.
The Department is accepting public comments until March 2, 2026. Personalized comments, including individual experiences, data, and programmatic impacts, are essential, as form letters are not counted.
Submit a Public Comment: Provide a personalized comment to the Department of Education on how reduced loan limits would affect audiology education and patient care.
Recent Posts
Audiology CPT® Codes Enter Routine AMA RUC Review Process
Over the next several months, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…
Academy Advocacy on Capitol Hill for Student Loan Reform and EHDI Support
Last week, Joanne Zurcher, MPP, and Academy member Melissa Heche, AuD, traveled to Capitol Hill to advocate for two important Academy priorities: protecting access to…
A New Era in Hearing Care: FDA Approves OTOF Gene Therapy
In the United States, mutations in the OTOF-gene (otoferlin gene) account for between one percent and eight percent of non-syndromic congenital hearing loss (Ford et…


